Journal
MULTIPLE SCLEROSIS AND RELATED DISORDERS
Volume 4, Issue 1, Pages 6-17Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.msard.2014.10.001
Keywords
Multiple sclerosis; Pregnancy; Reproduction; Birth outcome; Pregnancy registry
Categories
Funding
- Canadian Institutes of Health Research (CIHR)
- Teva Neurosciences
- Biogen Idec
Ask authors/readers for more resources
Multiple sclerosis (MS) is the most commonly acquired neurological disorder affecting young adults of reproductive age with an approximately 3:1 female to male ratio. Although pregnancy is not contraindicated in MS, data are limited regarding pregnancy outcome among MS patients, and the safety or risk to the fetus associated with most maternal MS treatments, such as disease modifying therapies (DMTs), during pregnancy is unknown. We review available epidemiological and registry data on MS and pregnancy and discuss the need to initiate a North American Multiple Sclerosis Pregnancy Registry that will prospectively identify pregnancies in women with MS, obtain information on the disease, and its treatment during gestation and lactation and follow the children to determine their health status. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available